AnaptysBio Inc
Biotechnology
Healthcare
ANAB
28.89 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
16.54
52 week high
40.33
high
18.13
52 week low
12.38
low
15.40
growth
-29.41 %
previous Close
16.98
P/E ratio
-15
market cap
443 M
div yield
0
net incoming
-32.85 M
29.59 %
net profit margin
-109.44 %
315.00 %
operating incoming
-22.76 M
43.56 %
net change in cash
120 M
560.71 %
cash on hand
192 M
166.75 %
cost of revenue
596 K
0.17 %
top